El interés en corto de 60 Degrees da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de 60 Degrees. Los datos de interés en corto se actualizan cada dos semanas.

60 Degrees (NASDAQ:SXTP) Bolsa, Informe de interés en corto

60 Degrees

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. - Warrant

<a href="https://www.youtube.com/live/8rQlEH86FCM?si=s1GWbEOy5eqm4Jq5" title="https://www.youtube.com/live/8rQlEH86FCM?si=s1GWbEOy5eqm4Jq5">https://www.youtube.com/live/8rQlEH86FCM?si=s1GWbEOy5eqm4Jq5</a>

News

Federal Reserve

FPowell In Near Term Election Will Have No Effect On Policy Decision; Economy Difficult To Forecast; Don't Know Timing, Substance Of Policy Changes; Economy Hard To Forecast Beyond Near Term; Therefore Dont Know How Policies Would Matter To Fed's Goals; We Don't Guess; Dont Guess, Speculate Or Assume; Possible That Any Administration Or Congress Policies Could Have An Effect That Matters; Those Effects Would Be Taken In Account Among Others

WIIM

TSX:ENS

EnerSys shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results. Additionally, the company CEO and president announced his intention to retire, effective May 2025.

Morgan Stanley analyst Joseph Moore maintains Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) with a Equal-Weight and lowers the price target from $207 to $204.

Price Target

Analyst Ratings

QCOM

Morgan Stanley Maintains Equal-Weight on Qualcomm, Lowers Price Target to $204

Tigress Financial analyst Ivan Feinseth maintains Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Buy and raises the price target from $210 to $270.

Tigress Financial Maintains Buy on Royal Caribbean Gr, Raises Price Target to $270

<a href="https://www.youtube.com/watch?v=8rQlEH86FCM" title="https://www.youtube.com/watch?v=8rQlEH86FCM">https://www.youtube.com/watch?v=8rQlEH86FCM</a>

Fed's Powell Says Risks To Achieving Goals Roughly In Balance; Today Fed Lowered Rate As Further Recalibration Of Policy Stance; Policy Stance Will Move Toward Neutral Stance Over Time; Not On Preset Course; Decisions Meeting By Meeting; Policy Will Adjust To Promote Goals; If Economy Remains Strong, Inflation Not Moving To 2% Can Dial Back Policy More Slowly; Policy Is Well Positioned Relative To Risks

Morgan Stanley analyst Matthew Cost maintains DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with a Equal-Weight and lowers the price target from $23 to $21.

Morgan Stanley Maintains Equal-Weight on DoubleVerify Hldgs, Lowers Price Target to $21

Macquarie analyst Paul Golding maintains Six Flags Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a Outperform and maintains $55 price target.

Macquarie Maintains Outperform on Six Flags Entertainment, Maintains $55 Price Target

Macro Economic Events

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher after the Fed cut rates by 25 bps. Investors also continue to assess the 2024 US presidential election.

Fed's Chair Powell Says Labor Market Solid; Unemployment Rate Has Edged Down In Past 3 Months, Remains Low; Wage Growth Has Eased; Labor Market Conditions Less Tight Than Pre-Pandemic; Labor Market Not A Source Of Inflation Pressures; Overall Inflation Has Moved Much Closer To Goal;  Core Inflation Remains Elevated; Policy Is Guided By Dual Mandate

Morgan Stanley analyst Brian Nowak maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Overweight and raises the price target from $185 to $200.

TTWO

Morgan Stanley Maintains Overweight on Take-Two Interactive, Raises Price Target to $200

BWS Financial analyst Hamed Khorsand maintains Xperi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>) with a Top Pick and maintains $30 price target.

XPER

BWS Financial Maintains Top Pick on Xperi, Maintains $30 Price Target

Morgan Stanley analyst James Faucette maintains Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) with a Equal-Weight and raises the price target from $65 to $90.

QTWO

Morgan Stanley Maintains Equal-Weight on Q2 Holdings, Raises Price Target to $90

<a href="https://www.detroitnews.com/story/business/autos/general-motors/2024/11/07/gm-ending-cadillac-xt4-production-in-january/76112996007/#:~:text=General%20Motors%20Co.%20is%20ending,Malibu%20sedan%20ended%20this%20month" title="https://www.detroitnews.com/story/business/autos/general-motors/2024/11/07/gm-ending-cadillac-xt4-production-in-january/76112996007/#:~:text=General%20Motors%20Co.%20is%20ending,Malibu%20sedan%20ended%20this%20month">https://www.detroitnews.com/story/business/autos/general-motors/2024/11/07/gm-ending-cadillac-xt4-production-in-january/76112996007/#:~:text=General%20Motors%20Co.%20is%20ending,Malibu%20sedan%20ended%20this%20month</a>.

'GM ending Cadillac XT4 production in January' - Detroit News

Fed's Chair Powell Says Economy Is Strong; Labor Market Remains Solid; Inflation Has Eased Substantially; Committed To Maintaining Economy's Strength; Fed Took Another Step In Reducing Policy Restraint; Continue To Be Confident That With Recalibration Of Stance, Inflation Moves Sustainably Down To 2%

ARDT

Ardent Health Partners shares are trading higher after the company raised its FY24 guidance.

SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading relatively flat on Thursday.</a>
Yesterday, the company reported third-quarter results, with revenues of $260.9 million, down 2% from $265.4 million in the prior quarter and down 64% from $725.3 million in the same quarter last year.
Revenues from the solar segment were $247.5 million, down 63% from $676.9 million in the same quarter last year.
Here are the analysts&#8217; takes on the <a target="_blank" href="https://www.benzinga.com//node/41806208" rel="noreferrer noopener">earnings results</a>:
Piper Sandler analyst Kashy Harrison downgraded the stock to Underweight from Neutral, lowering the price forecast to $9 from $17.
The analyst sees cash flow challenges ahead due to normal DSOs/DPOs, weak sales, rising U.S. manufacturing costs, European issues, and the Tesla threat.
The analyst suggests a capital raise and major cost cuts are necessary for survival. Harrison widens the FY24 loss estimate per share to $(21.08) from $(7.20).
Truist Securities analyst Jordan Levy reiterated the Hold rating on the stock, with an unchanged price forecast of $20.
According to the analyst, the topline miss is primarily due to continued weakness in Europe, where MW volumes fell over 30%, while North American volumes rose by a similar percentage.
Further, topline and the gross margin guidance for the fourth quarter fell short of Street estimates, while the Opex guidance was slightly below the Street estimates.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41807202/microsoft-shows-room-to-climb-as-tesla-nvidia-amazon-near-52-week-highs" rel="noreferrer noopener">Microsoft Shows Room To Climb As Tesla, Nvidia, Amazon Near 52-Week Highs</a>
Roth MKM analyst Philip Shen reiterated the Neutral rating on the stock, loweing the price forecast to $12 from $20.
The largest third-quarter writedowns were for excess and obsolete inventory, as the company no longer expects to sell it due to reduced demand in the EU, Shen notes.
The analyst writes that the company aims to return to profitability by focusing on financial stability, regaining market share, and refocusing on core businesses.
It is also reducing costs, streamlining operations in profitable markets, and investing in technology for future growth, Shen notes.
KeyBanc Capital Markets analyst Sophie Karp noted that the company is banking on strong demand for U.S.-made products, alongside new offerings and software, to fuel growth in the next industry cycle.
However, the ongoing demand slump, coupled with recent election developments, is likely to dampen investor interest for now, the analyst writes. The analyst rates SEDG shares Sector Weight.
Price Action: SEDG shares are trading lower by 1.41% to $14.47 at last check Thursday.
Image via Pixabay
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41794926/trump-white-house-could-unlock-trillion-dollar-ai-potential-for-tesla-says-dan-ives" target="_blank" rel="noreferrer noopener">Trump White House Could Unlock Trillion-Dollar AI Potential For Tesla, Says Dan Ives</a></li>
</ul>

Analyst Color

Equities

Downgrades

Reiteration

Markets

Movers

Trading Ideas

General

SEDG

TSLA

SolarEdge Q3 Results Miss Expectations; Analysts Warn Of Cash Flow Challenges And Need For Cost Cuts

Whales with a lot of money to spend have taken a noticeably bullish stance on Arista Networks.
Looking at options history for Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 23% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $522,189 and 21, calls, for a total amount of $964,976.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $370.0 to $600.0 for Arista Networks during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Arista Networks's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Arista Networks's whale activity within a strike price range from $370.0 to $600.0 in the last 30 days. 
<h3>Arista Networks Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731007897_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$9.5</td>
<td>$9.2</td>
<td>$9.36</td>
<td>$370.00</td>
<td>$362.4K</td>
<td align="right">115</td>
<td align="right">392</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$88.5</td>
<td>$86.2</td>
<td>$87.3</td>
<td>$430.00</td>
<td>$87.3K</td>
<td align="right">60</td>
<td align="right">49</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$88.3</td>
<td>$84.9</td>
<td>$86.65</td>
<td>$430.00</td>
<td>$86.6K</td>
<td align="right">60</td>
<td align="right">24</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$88.4</td>
<td>$88.0</td>
<td>$88.0</td>
<td>$430.00</td>
<td>$70.4K</td>
<td align="right">60</td>
<td align="right">115</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$14.0</td>
<td>$14.0</td>
<td>$14.0</td>
<td>$440.00</td>
<td>$70.0K</td>
<td align="right">692</td>
<td align="right">51</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
In light of the recent options history for Arista Networks, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Arista Networks Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,293,445, with ANET's price up by 1.21%, positioned at $428.26.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About Arista Networks</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $460.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Arista Networks with a target price of $460. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Arista Networks, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

ANET

Decoding Arista Networks's Options Activity: What's the Big Picture?

Investors with a lot of money to spend have taken a bearish stance on BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BLK, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for BlackRock.
This isn't normal.
The overall sentiment of these big-money traders is split between 12% bullish and 50%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $88,735, and 5 are calls, for a total amount of $747,184.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $470.0 to $1100.0 for BlackRock during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for BlackRock's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across BlackRock's significant trades, within a strike price range of $470.0 to $1100.0, over the past month.
<h3>BlackRock 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731007893_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$586.0</td>
<td>$579.0</td>
<td>$581.38</td>
<td>$470.00</td>
<td>$465.1K</td>
<td align="right">9</td>
<td align="right">8</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$202.6</td>
<td>$184.3</td>
<td>$192.0</td>
<td>$990.00</td>
<td>$134.4K</td>
<td align="right">7</td>
<td align="right">0</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$37.1</td>
<td>$30.6</td>
<td>$33.8</td>
<td>$1010.00</td>
<td>$67.6K</td>
<td align="right">106</td>
<td align="right">20</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$265.6</td>
<td>$258.5</td>
<td>$259.9</td>
<td>$800.00</td>
<td>$51.9K</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr>
<td>BLK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$45.1</td>
<td>$44.4</td>
<td>$45.1</td>
<td>$1050.00</td>
<td>$31.5K</td>
<td align="right">17</td>
<td align="right">7</td>
</tr>
</tbody>
</table>

<h3>About BlackRock</h3>
BlackRock is the largest asset manager in the world, with $11.475 trillion in assets under management at the end of September 2024. Its product mix is fairly diverse, with 55% of managed assets in equity strategies, 26% in fixed income, 9% in multi-asset classes, 7% in money market funds, and 3% in alternatives. Passive strategies account for around two thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which by our calculations account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one third of managed assets coming from investors domiciled outside the US and Canada.
<h3>Current Position of BlackRock</h3>
<ul>
<li>With a trading volume of 270,360, the price of BLK is up by 0.82%, reaching $1038.21.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 64 days from now.</li>
</ul>
<h3>Expert Opinions on BlackRock</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $1052.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on BlackRock with a target price of $1077. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on BlackRock, maintaining a target price of $1070. 
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on BlackRock, which currently sits at a price target of $914. 
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on BlackRock, maintaining a target price of $1160. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on BlackRock with a target price of $1040. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for BlackRock, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

This Is What Whales Are Betting On BlackRock

Investors with a lot of money to spend have taken a bullish stance on BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BILL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for BILL Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 37%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $127,025, and 5 are calls, for a total amount of $411,563.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $45.0 to $80.0 for BILL Holdings during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of BILL Holdings stands at 229.5, with a total volume reaching 1,400.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in BILL Holdings, situated within the strike price corridor from $45.0 to $80.0, throughout the last 30 days.
<h3>BILL Holdings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731007887_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BILL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$3.0</td>
<td>$2.7</td>
<td>$3.0</td>
<td>$67.00</td>
<td>$141.3K</td>
<td align="right">306</td>
<td align="right">477</td>
</tr>
<tr>
<td>BILL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$19.0</td>
<td>$17.6</td>
<td>$18.39</td>
<td>$47.50</td>
<td>$73.5K</td>
<td align="right">8</td>
<td align="right">40</td>
</tr>
<tr>
<td>BILL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$12.0</td>
<td>$10.5</td>
<td>$12.1</td>
<td>$55.00</td>
<td>$72.6K</td>
<td align="right">849</td>
<td align="right">64</td>
</tr>
<tr>
<td>BILL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.9</td>
<td>$15.9</td>
<td>$16.51</td>
<td>$50.00</td>
<td>$66.0K</td>
<td align="right">522</td>
<td align="right">40</td>
</tr>
<tr>
<td>BILL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$21.2</td>
<td>$20.0</td>
<td>$20.72</td>
<td>$45.00</td>
<td>$58.0K</td>
<td align="right">1</td>
<td align="right">28</td>
</tr>
</tbody>
</table>

<h3>About BILL Holdings</h3>
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.
In light of the recent options history for BILL Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of BILL Holdings</h3>
<ul>
<li>Currently trading with a volume of 1,332,456, the BILL's price is up by 1.34%, now at $65.58. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 0 days.</li>
</ul>
<h3>What The Experts Say On BILL Holdings</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $61.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Neutral rating on BILL Holdings with a target price of $60. 
&#x2A; An analyst from Baird has decided to maintain their Neutral rating on BILL Holdings, which currently sits at a price target of $62. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for BILL Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

BILL

BILL Holdings Unusual Options Activity

Barrington Research analyst James Goss maintains Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) with a Outperform and maintains $12 price target.

Barrington Research Maintains Outperform on Warner Bros. Discovery, Maintains $12 Price Target

In a report released today, Edward White from H.C. Wainwright maintained a Hold rating on 60 Degrees Pharmaceuticals, Inc. (SXTP – Research Report)...

H.C. Wainwright Keeps Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
60 Degrees Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) stock is gaining on Monday after the specialty pharmaceutical company <a href="https://finance.yahoo.com/news/60-degrees-pharma-provides-university-131200159.html">announced an agreement</a> with the University of Kentucky.



This agreement will have the University of Kentucky conducting a Phase IIb clinical trial of SJ733. This is a drug candidate in development by 60 Degrees Pharmaceuticals for the treatment of vivax malaria.



This study will cover the use of SJ733 alongside tafenoquine to treat vivax malaria. The information from this study will also be applied to 60 Degrees Pharmaceuticals New Drug Application (NDA) for the drug.



Dr. R. Kip Guy, the principal investigator of the study, said the following about it:




&ldquo;Innovations in treating P. vivax malaria, which infects an estimated 14 million people a year, have been limited in recent decades. The upcoming study of SJ733 combined with tafenoquine has the potential to pave the way for very meaningful improvement in malaria treatment around the world.&rdquo;




<h2>What This Means for SXTP Stock</h2>



This new clinical trial news has SXTP stock heading higher on Monday with heavy trading of the shares. That has more than 11.9 million shares changing hands as of this writing. To put that in perspective, the company&rsquo;s daily average trading volume is about 448,000 shares.



SXTP stock is up 28.9% as of Monday afternoon.



There are even more stock market stories traders are going to want to read about below!



We have all of the hottest stock market news ready to go on Monday! A few examples include what&rsquo;s going on with shares of Draganfly&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dpro-stock-quote/">DPRO</a>), KeyBank (NYSE:<a href="https://investorplace.com/stock-quotes/key-stock-quote/">KEY</a>) and Archer Aviation&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/achr-stock-quote/">ACHR</a>) stock today. All of this news is available at the following links!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-draganfly-dpro-stock-up-37-today/">Why Is Draganfly (DPRO) Stock Up 37% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/key-stock-surge-alert-whats-going-on-with-keycorp-shares-today/">KEY Stock Surge Alert: What&rsquo;s Going On With KeyCorp Shares Today?</a></li>



<li><a href="https://investorplace.com/2024/08/achr-stock-3-things-for-investors-to-know-about-the-370-million-stellantis-deal/">ACHR Stock: 3 Things for Investors to Know About the $370 Million Stellantis Deal</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-60-degrees-pharmaceuticals-sxtp-stock-up-29-today/">Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 29% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 29% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) just reported results for the second quarter of 2024.<ul><li>60 Degrees reported earnings per share of -$4.23. This was below the analyst estimate for EPS of -23 cents.</li><li>The company reported revenue of $124,972.</li><li>This was 37.51% worse than the analyst estimate for revenue of $200,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/sxtp-stock-earnings-60-degrees-for-q2-of-2024/">SXTP Stock Earnings: 60 Degrees Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SXTP Stock Earnings: 60 Degrees Misses EPS, Misses Revenue for Q2 2024

H.C. Wainwright Sticks to Their Hold Rating for 60 Degrees Pharmaceuticals, Inc. (SXTP)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Outlook Therapeutics (OTLK – Research Report), 60 ...

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS)

60 Degrees Pharmaceuticals GAAP EPS of -$4.23

Earnings week ahead: Zoom, Lowe's, Target, Baidu, XPeng, Zim Integrated and more

60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall

H.C. Wainwright analyst Edward White maintained a Hold rating on 60 Degrees Pharmaceuticals, Inc. (SXTP – Research Report) today. The company's sha...

H.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)

Warning: SXTP is at high risk of performing badly

ASND

AYRO

BIDU

BILI

BTBT

CARA

CATO

COTY

CSIQ

CTXR

ESTC

FORD

FUTU

GGAL

GRTS

IMMR

INTU

JKHY

KEYS

MBRX

MMAT

NNDM

NNOX

NTES

OTLK

PANW

PTON

ROST

SEEL

SNOW

SNPS

SXTP

URBN

VIPS

WDAY

WKHS

WOLF

XPEV

Health Care

Press Releases

60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment

60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

Contracts

60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support

60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split

60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study

Earnings

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements

60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Financing

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch

Comments

60 Degrees

Interés en corto

60 Degrees (NASDAQ:SXTP) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL